Oncology News

Bariatric surgery was associated with a decreased incidence of esophageal and gastric cancer as well as in-hospital mortality in a cohort of patients with severe obesity, according to results published in JAMA Surgery.

Geneoscopy announced it submitted an FDA premarket approval application for the noninvasive, stool-based, at-home screening test for colorectal cancer and advanced adenomas, according to a company release.

Single-fraction radiation therapy reduced hepatic pain among most patients with end-stage hepatocellular carcinoma or liver metastases, according to randomized phase 3 study results presented at ASCO Gastrointestinal Cancers Symposium.

Stereotactic body radiation therapy followed by sorafenib extended survival compared with sorafenib alone among patients with hepatocellular carcinoma, according to study results presented at ASCO Gastrointestinal Cancers Symposium.

Adjuvant therapy with atezolizumab and bevacizumab reduced recurrence risk compared with active surveillance for patients with certain types of early-stage liver cancer, according to topline data released by the agents’ manufacturer.

Excess weight, regardless of polygenic risk score, correlated with an increased risk for colorectal cancer, according to results from a population-based, case-control study.

Researchers reported low prevalence for advanced colorectal neoplasms at screening colonoscopies conducted at least 10 years after a negative index colonoscopy, especially among women younger than 75 years.

Researchers have proposed a machine-learning algorithm for personalized treatment selection in patients with recurrent hepatocellular carcinoma, based on data published in JAMA Surgery.

Cost-effectiveness analysis revealed limited differences between laparoscopic vs. open gastrectomy at 1-year follow-up among a cohort of Dutch patients with gastric cancer, according to results published in JAMA Surgery.

Geneoscopy Inc. announced favorable results from its CRC-PREVENT trial, which assessed noninvasive, stool-based, at-home screening for colorectal cancer and advanced adenomas.